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Abstract. Here we show how dynamic nuclear polarization (DNP) nuclear magnetic resonance (NMR) spectroscopy 
experiments permit the atomic level structural characterization of loaded and empty lipid nanoparticles (LNPs). The LNPs 
used here were synthesized by microfluidic mixing technique and are composed of ionizable cationic lipid (DLin-MC3-
DMA), a phospholipid (DSPC), cholesterol and PEG (DMPE-PEG 2000), as well as encapsulated cargoes which are either 
phosphorothioated-siRNA (50 or 100%) or mRNA. We show that LNPs form physically stable complexes with bioactive 
drug siRNA for a period of 94 days. Relayed DNP experiments are performed to study 1H-1H spin diffusion and to determine 
the spatial location of the various components of the LNP by studying the enhancement factors as a function of polarization 
time. We observe a striking feature of LNPs in the presence and in the absence of encapsulating siRNA or mRNA by 
comparing our experimental results to numerical spin diffusion modelling. We observe that LNPs form a layered structure 
and we detect that DSPC and DMPE-PEG 2000 lipids form a surface rich layer in the presence (or absence) of the cargoes, 
and that the cholesterol and ionizable cationic lipid are embedded in the core. Furthermore, relayed DNP 31P solid-state 
NMR experiments allow the location of the cargo encapsulated in the LNPs to be determined. Based on the results we 
propose a new structural model for the LNPs which features a homogeneous core with a tendency for layering of DSPC and 
DMPE-PEG at the surface.   
Introduction	
A challenge in medicine today is the ability to deliver 
drugs to specific targets, for example, to inhibit cancer 
cells without damaging the surrounding healthy tissues.1 
Cell membranes are mostly composed of lipid bilayers, 
and their hydrophobic nature protects the cells from 
hydrophilic molecules in the extracellular matrix.2-3 To 
achieve cellular internalization of hydrophilic bioactive 
molecules, many carrier-mediated delivery systems have 
been proposed. These include for example ionizable 
cationic lipid DOTMA (N-[1-(2,3-dioley;oxy)propyl]- 
N,N,N- trimethylammonium chloride) and DLinDMA 
(1,2-dilonoleyloxy-3-dimethylaminopropane),4 
semiconductor nanocrystals,5 carbon nanotubes,6 
dendrimers,7 natural or synthetic polymers,8 or cell 
penetrating peptides.9-10 However, most of these systems 
may show clinical side-effects and have not been 
approved for in-vivo applications or low efficacy because 
of poor cellular uptake or clearance by the mononuclear 
phagocyte system. Lipid nanoparticles (LNPs) show the 
high promise to overcome these disadvantages for drug-
delivery of small interfering RNA (siRNA) or messenger 
RNA (mRNA) since they can form less toxic highly 
stable complexes between the cargo and the LNP and 
achieve target-specific cellular internalization and release 
of hydrophilic bioactive molecules.2, 4, 11-15 LNPs are 
spontaneously formed from amphiphilic and hydrophobic 
constituents to yield complex multicomponent objects 
known to span a range from 20 to 100 nm in diameter 
depending on composition.16 The cargo molecules are 
typically drugs such as siRNA and mRNA.17-18 siRNA 
inhibits endogenous gene expression in mammalian cells 
and induces degradation of complementary mRNA.17 
mRNA promotes the right protein expression.19  
Encapsulation of siRNA or mRNA in LNPs prevents 
their degradation by nucleases and enables penetration 
and delivery to the target cells.  
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Scheme 1. Cartoon diagrams of three models for LNP structures. (a) Multilamellar vesicles (onion), (b) nanostructure core, and (c) 
homogeneous core shell
The drug encapsulation and delivery properties can be 
assumed to be dependent on the exact structure of the 
LNP, but due to their complexity, there is currently no 
clear model for LNP structures. Indeed, even the ageing 
of the particles has not been studied at the molecular 
level. Furthermore, several models for these self-
assembled particles have been proposed in the 
literature,16 including multilamellar vesicles (Scheme 
1a), 20-22 and particles with nanostructured cores (Scheme 
1b).23-24 However these structures are still in debate.16 
Here, we use dynamic nuclear polarization (DNP) 
enhanced NMR spectroscopy to probe the spatial 
distribution of constituents in LNPs in the presence and 
absence of siRNA and mRNA, and as a result we propose 
a new structural model that features a homogeneous core 
with a tendency toward layering which is different from 
what is described in literature (Scheme 1C).  
Even though there are now multiple studies aimed at 
characterizing the internalization of a cargo by LNPs 
using a variety experimental approaches there is still no 
consensus on the structural organisation of LNPs. To 
date, the approaches applied to characterize LNPs have 
included DLS to measure particles sizes,16, 25 31P solution 
NMR to measure encapsulation of siRNA,24 cryo-
transmission electron microscopy (cryo-TEM) to study 
the overall structure,26 or density measurements to probe 
constitution and molecular modeling to support different 
structural models.6  Small angle X-ray scattering (SAXS) 
and small angle neutron scattering (SANS) have also 
been used to characterize the phase behaviour and 
polymorphism of LNP dispersions,27-28 and exchange 
with the cargo.29 
In order to probe the detailed structure of the LNPs, one 
would ideally like to measure the spatial distribution of 
the different components inside the particles. 
Traditionally, NMR spectroscopy is the leading method 
for probing structure and morphology of lipid 
assemblies.30-31 In particular, for LNPs, Leung et al. have 
successfully observed encapsulation of siRNA using 
solution 31P NMR experiments.7 They observed 
broadening of the 31P resonances of phosphorothioate 
siRNA upon encapsulation within the LNP. The 
broadening of the siRNA 31P NMR signal suggests that 
upon encapsulation, the siRNA becomes less mobile, 
indicating that siRNA mainly resides in the lipid phase of 
the LNP particles rather than in internal water pools, 
where the siRNA could remain mobile.  
It is well established that proton spin-diffusion 
measurements can be used to determine domain sizes and 
organisations in a range of materials (substituents) 
including solid polymer blends,32 and this would appear 
to be a promising approach to determine the domain 
structures in LNPs. In particular it has recently been 
shown that spin diffusion of DNP enhanced polarization 
from a radical containing source phase into a substrate, 
dubbed relayed-DNP, can be used to determine domain 
sizes and architectures in complex multi-component 
mixtures.33-37 The approach has been used to determine 
particle or domain sizes in pharmaceutical 
formulations,34 biomolecules38 and microcrystalline 
solids,33 and similar concepts have been used to probe 
layer dimensions in the supramolecular organization of 
biosilica.39 When sensitivity is high enough, the approach 
can also be used based on the diffusion of a paramagnetic 
relaxation enhancement, without the need for DNP.36 
Here we apply relayed DNP experiments to frozen 
LNPs in the presence of cryoprotectant to probe the layer 
structures of LNPs in the presence (or not) of 
phosphorothioated-siRNA or mRNA. First, we determine 
that the LNPs show no change in the NMR properties for 
a period of more than 90 days. Then, we compare our data 
to predictions for the three models shown in Scheme 1, 
and find that our DNP results show a layered structure for 
these 50 nm complex lipid nanoparticles (Scheme 1c). 
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We also probe the location of the cargo, and can 
distinguish its location between the core, sub-core or 
surface of the LNP.  
Experimental Section 
Synthesis. D2O-LNP solutions with concentrations of 
LNP of 60 mg/mL were manufactured using microfluidic 
mixing. The nanoparticles were dialyzed overnight in 
PBS 7.4 in order to remove EtOH and lower the pH, and 
then concentrated by ultra-spin filtration. The 
surrounding H2O was exchanged to D2O during this 
process by repeated cycling and equilibration.  The LNP 
samples were prepared with pure D2O since partial 
deuteration of the solvent is usually beneficial for DNP 
and the components of the LNP were fully protonated. 
With the high concentration of protonated LNP 
components, this should make the overall proton 
concentration similar to 90% deuterated water-glycerol 
solutions that typically provide the highest DNP 
enhancements.  All LNP samples are stored in a 4 °C 
refrigrator and vortexed or shacked 30 times before use 
in DNP experiments to prevent aggregation of the LNP. 
Dynamic Light Scattering. The mean diameter (Z-
Average  or number based average) and polydispersity 
(PDI) of the LNPs was determined using a Zetasizer 
Nano-ZS (Malvern Instruments Ltd). Dynamic light 
scattering was performed on  diluted samples in 10 mM 
phosphate buffer at 25°C using a refractive index of 1.45 
and an absorption of 0.001 for the LNPs. Data was 
collected at 173° and the reported diameter is a mean of 
3 values. Results are to be found in Supporting 
information, Table S1. 
DNP experiments. All samples were prepared by 
adding 30 % by volume of cryo-protectant (12C-glycerol-
d8) to 70 % by volume of LNP sample and 12 mM 
polarizing agent (AMUPol, MW= 726 g/mol).  Typically, 
20-25 µL of the sample solution described above was 
transferred using a micro-pipette to a 3.2 mm o.d. 
sapphire rotors and capped with a silicon plug.  Data were 
acquired at the Ecole Polytechnique Fédérale de 
Lausanne using 263 GHz/400 MHz Avance I Bruker 
DNP solid-state NMR spectrometer (νL(13C) = 100.6 
MHz, νL(31P) = 161.976 MHz) equipped with a 3.2 mm 
Bruker triple resonance low temperature magic angle 
spinning (LTMAS) probe and the experiments were 
performed at ca. 100 K with a 263 GHz gyrotron capable 
of outputting a 5-10 W of CW microwaves. The sweep 
coil of the main magnetic field was set for the µwave 
irradiation occurring at the 1H positive enhancement 
maximum of the AMUPol biradical. Following this is the 
usual spectral acquisition for 13C, 31P, and 1H under 
CPMAS conditions with spinal64 proton 100 kHz 
decoupling. Experimental setup and pulse calibration 
were performed directly on the compound and referenced 
to the 1H solvent peak following recommendation 10 of 
P. K. Harris et al. for other nuclei in the solid state. 40 
DNP enhanced 31P solid-state NMR. 31P SSNMR 
experiments used a recycle delay of 1 s at 9.4 T.  The 
proton π/2 pulse length was optimized to 2.50 µs 
providing a 100 kHz proton decoupling.  The contact time 
was 1.4 ms. The spinning frequencies varied between 4 
kHz and 12.5 kHz.  The CPMAT experiment was 
acquired un the following conditions: a recycle delay of 
1.75s, 336 scans per increment for a total of 112 at 105 
K.   
DNP enhanced 13C solid-state NMR. For 13C NMR 
experiments, the recycle delays were 1 s.  The 1H π/2 
pulse length used for the CP experiments was 2,5 µs to 
afford 100 kHz 1H decoupling. The contact time was 
typically 20 ms. The MAS frequency used is 10 kHz. 
Spectra were simulated using WSOLIDS.41 DNP 
enhancements were determined by comparing the 
integration of the resonance of interest for the spectra 
acquired with and without µwave. Numerical spin 
diffusion models were constructed with MatLab v7.10. 
(The MathWorks, Inc.).  Additional experimental details 
may be found in the SI. 
Results 
The studies were carried out on LNPs composed of the 
four constituents shown in Figure 1, an ionizable cationic 
lipid (DLin-MC3-DMA), a phospholipid (DSPC), 
cholesterol and a pegylated lipid (DMPE-PEG 2000). As 
described in detail below, 1H, 13C and 31P cross 
polarization42 magic angle spinning43-44 (CPMAS) 
experiments were used to probe the various components 
of the LNPs which are found to have different chemical 
shifts (δ) and DNP enhancements (ε). 31P chemical shift 
anisotropy (CSA) was measured experimentally and 
interpreted in relation to the electrostatic interaction 
between LNPs and cargoes, such as siRNA or mRNA. 
The high sensitivity enhancements offered by DNP 
enabled the detailed study of frozen LNP solutions with 
or without encapsulated cargo. Relayed DNP techniques 
were applied to probe the relative location of the different 
components in the LNP core, or exterior shell, as well as 
to probe the position of the cargo.37 
Initial Characterization. Four samples were studied 
here: native empty LNP (1); LNP containing 50% 
phosphorothioated siRNA strand (2) or at 100% 
phosphorothioated (3) and LNP containing mRNA (4). 
The concentration of each component forming the LNPs 
is given in Table S2Error! Reference source not 
found.. The synthesis as well as the encapsulation of the 
cargo is described in the supporting information together 
with size distributions of each sample obtained from 
DLS.  
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Figure 1. Components of the LNPs studied here. See 
composition ratios in Table S2 in SI.  The functional groups 
observed for LNPs are resolved in the 13C spectra, and are 
color coded to the following legend: alkenes (R-HC=CH-R), 
ester (R-CO2-CH2-R) and Cα-phosphate R-CαH2-PO43-) are 
in blue, yellow, purple, and pink, respectively. 
LNP stability and ageing. Figure 2 shows DNP 
enhanced 13C CPMAS solid-state NMR spectra of the 
LNP sample 2 taken over a period of 164 days. Samples 
were prepared for each time point by mixing an LNP-D2O 
(60 mg/ml) solution with 12C-glycerol-d8 to form a 70:30 
v/v ratio dispersion and adding AMUPol to afford a 
concentration of 12 mM. The sample was transferred into 
a sapphire DNP rotor, then frozen inside the pro-cooled 
DNP probe. The chemical shifts and the observed 
enhancements at long polarization time are given in Table 
S5 and S6. Due to the high sensitivity provided by DNP 
method the natural abundance 13C solid-state NMR 
spectra can be recorded in minutes, while the microwave 
off spectra were recorded in about an hour. There is no 
significant change in the peak positions in the spectra or 
the enhancements for the first 94 days, illustrating that the 
formulations are stable over this period. In this procedure, 
the batch of LNPs were stored at 277 K and a new DNP 
sample was prepared for each measurement. A spectrum 
taken after 164 days shows the same peak positions, but 
with an enhancement that drops to 11, this strongly 
indicates that the components are still intact, but that we 
see the onset of particle aggregation. Note that in the 
study of fresh LNP samples, multiple freeze thaw cycles 
in liquid nitrogen were performed to confirm that the 
samples are re-dispersible, hence not affected by freezing 
(not shown). 
 
 
Figure 2. 1H-13C CPMAS solid-state NMR spectra of 
sample 2 acquired with a 400 MHz/263 GHz DNP system at 
different times (left) with microwave (µwave) irradiation on 
(40 mA, black trace) and off (dashed trace). The MAS 
frequency was between 8 kHz and 12.5 kHz with a 
temperature ca. at 105 K, and the recycle delay was 1.0 s.  
The silicone plug is observed in all spectra at a resonance of 
ca. 0 ppm. The components of the LNP are resolved in the 
13C spectra, and they are color coded according to the legend 
described in Figure 1, and the green line corresponds to the 
R–CH2-R alkyl signal. The vertical line illustrates that the 
chemical shifts are constant over time. Resonance at 170 
ppm corresponds to an external reference (13C=O labelled 
acetate) used to measure the DNP enhancement of the radical 
solution (complete details can be found in the SI). The 
enhancements are noted for the alkene peak at each time 
point (error in parenthesis).  
Spectra of (1) were also recorded, and also showed 
stability to 94 days. The data for (1) are shown in SI. We 
note that the different components of the LNPs are 
resolved in the 13C spectra, with alkane at 30 ppm, Cα-
phosphate (R- CαH2-PO43--) at 56 ppm, (H3CO-(CH2-
CH2-O)n-R) ester carbons at 69 ppm, alkene at 125 ppm 
and (R-CO2-CH2-R) ester carbons at 170 ppm.  
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Furthermore, some peaks arise exclusively from 
particular components of the LNP, such as the alkene 
resonance (125 ppm) which corresponds to the DLin-
MC3-DMA cationic lipid and cholesterol, the ester peak 
at 69 ppm from the DMPE-PEG 2000 and the Cα-
phosphate peak at 56 ppm from DSPC, whereas the 
resonances at 170 ppm and 30 ppm correspond to a 
superposition of signals from all the LNP components. 
There are no resolved 13C peaks characteristic of the 
siRNA or in the 1D spectra of LNP samples containing 
cargoes, since they overlap with the other constituents. 
This is further confirmed with a 2D 1H-13C HETCOR 
spectrum where all correlations are attributed to the LNP 
constituents (see SI, Figure S4).  
DNP Enhanced 31P Solid-State NMR. NMR signals 
from both RNA and the phosphate groups of the LNPs 
are observed in DNP enhanced 31P solid-state NMR 
spectra (Figure 3). The chemical shift of the phosphate 
(PO43-) functional group of DSPC and DMPE-PEG 
components are observed at 10 ppm in all systems, in 
agreement with the literature values.45-48 The 
phosphorothioate group of the siRNA (S=PO32-) 
resonates at an isotropic chemical shift of 67 ppm which 
permits differentiation from the PO43- functional groups 
of the LNP components. Figure 3d compares the DNP 
enhanced 31P CPMAS spectra of siRNA which is 100 % 
phosphorothioated dissolved in D2O and the 31P CPMAS 
spectra of samples 1, 3, and 4.  
Table 1. Experimental 31P CS tensor parameters.a 
sample δiso / ppm 
Ω / 
ppm b κ 
b 
1 PO4
3- 
LNP 10(4) 183(5) 0.33(0.04) 
3 PO4
3- 
LNP 7 (5) 182(5) 0.35(0.02) 
 S=PO3
2- 
siRNA 65(3) 200(12) 0.54(0.03) 
siRNA/D2O 
S=PO32- 
siRNA 67(4) 196(16) 0.39(0.03) 
4 PO4
3- 
LNP 7(5) 183(5) 0.31(0.02) 
a Error bounds are given in parentheses. b Isotropic 
chemical shift: δiso=(δ11 + δ22 + δ33)/3; span: Ω ≈ δ11 – δ33; 
skew: κ = 3(δ22 - δiso)/(δ11 – δ33), where δ11 ≥  δ22 ≥ δ33. 
The 31P CPMAS spectra were acquired with a 4.5 kHz 
MAS frequency in order to generate spinning sideband 
manifolds that can be fit to determine the 31P chemical 
shift tensors. It should be noted that for compound 3 a 31P 
CPMAT experiment was acquired in order to separate the 
chemical shift anisotropy (CSA) from the isotropic part, 
hence a slice of the 2D experiment provides a slow MAS 
spectrum. This type of experiment is ideal to resolve 
different sites and extract CSA information, which 
permits simulation of the chemical shift tensor without 
ambiguity (see SI for more details). The 31P chemical 
shift tensors extracted from these spectra are given in 
Table 1. 
 
Figure 3. Experimental 31P CPMAS DNP spectra (solid line) 
and simulated spectra (dashed lines) acquired with µwave on 
and a slow spinning speed (4.5 kHz) for sample (a) 4, (b) 3 
(100 % phosphorothioated cargo) and (c) 100% 
phosphorothioated siRNA dispersed in D2O and (d) 1. The 
centerbands are highlighted in blue at 10 ppm for the PO43- 
group of the lipids, and S=PO32- group of the cargo in red at 
68 ppm. 
Previous MD simulations and solution 31P experiments 
suggests that the cargo interacts through electrostatic 
interactions with the LNP, and more specifically through 
a RNA-cationic lipid interaction.23 Hence, we expect to 
observe a change in the chemical shift (CS) tensor for the 
phosphorothioate group of the siRNA when encapsulated 
in the LNP if electrostatic interactions are present 
between the LNP and siRNA. It  has previously been 
shown that the interaction of metal ions (Mg2+, Li2+, Cd2+, 
Na2+) with phosphate groups in DNA or nucleic acids 
induces about 5 ppm change in the span (W) and 0-10 
ppm change in isotropic chemical shift due to 
electrostatic interactions.46-50 The CS tensor values in 
Table 1 for the cargo components (S=PO32-) are found 
here to be the same within error, in the presence of LNPs 
or not. Hence, if the siRNA is interacting at all with the 
cations then the interactions are weak and might not be 
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observable by NMR. Also, as expected, the CS tensors of 
the lipid are the same in the presence or not of siRNA. 
Relayed-DNP Measurements. We used relayed-DNP34, 
37 to probe the morphology of the LNPs by estimating the 
relative position of the different LNP constituents with 
respect to the LNP surface (i.e., surface or core). 
Relatively higher DNP enhancements are expected for 
components located at the surface as they are easily 
hyperpolarized due to their proximity to the radical 
solution, and lower ε values will be observed for groups 
buried inside the LNP core, because polarization is lost 
during diffusion of polarization from the surface to the 
inside of the LNP domain.33-34, 39 
In the LNP systems 1, 2, 3 and 4 the enhancement 
values obtained are relatively small for the LNP 
components (ε  21-55) when compared to the 
enhancement factor of the radical solution (ε ≈ 100, see 
SI for complete details on measurements). This 
difference in the enhancement value is a clear indication 
that the LNPs are a heterogeneous system polarized 
through 1H-1H spin diffusion37 from the radical 
containing solution located outside the LNP domains. 
The experimentally observed 13C and 31P signal build-
up curves as a function of the polarization time are shown 
for empty and loaded LNPs in the supporting 
information. The build-up curves were fit with stretched 
exponential functions (see Equation 1) to the values given 
in Tables S8-S12. The observed stretching parameters β 
are different from 1, which is also consistent with a model 
of relayed polarization transfer into the particle. 33-34  
Figures S6-S15 (see SI) shows the measured ε for 13C 
and 31P resonances of the different components as a 
function of polarization delay for LNP samples 1, 2, 3, 
and 4. Apart from the first point, the enhancement is 
found to be constant as a function of polarization delay 
for each component, which is consistent with the 
expected (small) size of the LNPs (~50 nm), which means 
that they are polarized very rapidly.  
Discussion 
Proposed model structures for the lipid nanoparticles. 
No conclusion on atomic level organisation of LNPs has 
been reached yet. We have considered the following three 
possible models (see Scheme 1), as follows.  
Multilamellar vesicle model.21, 26 The multilamellar 
vesicle model includes concentric layered rings such that 
the exterior surface is formed of DMPE-PEG, 
cholesterol, DSPC and DLin-MC3-DMA. Within this 
exterior shell is a layer of water containing the cargo. The 
bilayer of lipids is then repeated, alternating with the 
water/cargo layer. 
Nanostructured core model.23-24 The nanostructured 
core model presents a hydrophobic core with a surface 
monolayer formed of a polyethylene glycol lipid. The 
hydrophobic core is formed of inverted cationic lipids 
that are separated by asymmetric water pores formed 
during LNP synthesis, along with homogeneously 
dispersed cholesterol and DSPC. Computer modeling 
suggests that no cargo such as siRNA is present inside the 
water cavities and predicts that the cargo interacts with 
the cationic lipid interface as well as with the lipids at the 
inner surface.23  
Homogeneous core shell. This model has the surfactant 
components (DMPE-PEG, DSPC, DLin-MC3-DMA, 
and cholesterol) homogeneously dispersed throughout 
the particle, with a thin shell, and the interior being made 
up of small evenly dispersed inverted micelles throughout 
the domain. The inverted micelles form small water 
pockets. The cargo is homogeneously dispersed 
throughout the structure. 
The multilamellar vesicle model to describe the 
structure of cargo/LNP systems has been ruled out by 
cryo-TEM, density measurements and molecular 
modeling.24 Cryo-TEM demonstrates the presence of 
hydrophobic cores inside the LNP, because the electron 
density increases when compared to the liposome 
system.24, 51  
Modeling of Relayed DNP. The small measured 
enhancement values (ε  21-55, SI) at long polarization 
times and rapid relaxation build up times with microwave 
irradiation on ((TB, on)  1- 2.5 s are consistent with 
particle diameters of less than 100 nm ( 36-53 nm, SI). 
Two models which represent the possible extreme 
cases of the LNP structure, homogeneous or layered 
domain, are compared by numerical proton spin diffusion 
simulations. The structures are shown in Scheme 2.  
 
Scheme 2. Scheme of models used to simulate numerically 
the proton spin diffusion behavior observed in the various 
LNP systems, where in (a) model I has a homogenous 
domain (b) model II adds a layer at the surface of the domain. 
The symbols Din, Dlay and Dout correspond to the different 
spin diffusion coefficients inside the LNP domain, layer and 
bulk radical solution, respectively.  
Figure 4 compares the best fits between the 
experimentally observed averaged enhancement (!) and 
the predictions of the numerical simulations for Model I 
and II. Note that for the simulations, we consider 
polydispersity of the LNP size, as measured by DLS. We 
also assume that the spin diffusion constants (D) inside 
the LNP and in the LNP layer (in the case of model II) 
are lower (Din  10-4 µm2s-1) than outside in the radical 
solution (Dout = 1·10-3 µm2s-1). The lower spin diffusion 
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constant inside the LNP is included to account for 
molecular dynamics which might be explained by 
additional mobile moieties such as methyl groups and 
alkane chains.37-38 Model I mimics a homogeneous core 
model which displays an equal value for the enhancement 
for all components. Model II represents a layered 
structure where the simulated polarization for the surface, 
core and global regions correspond to the LNP 
components: DSPC and DMPE-PEG, cholesterol and 
DLin-MC3-DMA, and the alkanes, respectively. Further 
details of the numerical models and the parameters used 
are given in the SI. 
We immediately see that for Model I, which 
corresponds to the homogeneous core structure where all 
LNP components are uniformly distributed in the 
domain, the simulations predict the same value of the 
enhancement for all the different components. This is 
clearly not in agreement with our data. In contrast, the 
simulations for Model II are in good agreement with the 
data and predict that we should see different values of the 
enhancements for the different components, with surface 
(layer)> global (average of layer and core) > core. As 
mentioned above, higher enhancements are expected for 
components localised closer to the polarization source at 
the surface. DSPC and DMPE-PEG have higher 
enhancements than the other components in all four LNP 
samples. This suggests there is an enrichment of DSPC 
and DMPE-PEG lipids at the surface of the particles, and 
that DLin-MC3-DMA and cholesterol are located in the 
core region of the LNP domain. 
 It is evident that the LNP size increases in going from 
empty LNPs to LNPs containing the most hydrophilic 
cargo (see SI) due to encapsulation of a hydrophilic 
cargo. This could occur due to an increase in internal 
water content that in turn results in an increase in LNP 
size as shown schematically in Figure 5. As the water 
content increases inside the LNP, the amphiphilic 
DMPE-PEG should no longer be as concentrated at the 
surface, but may be distributed further into the LNP due 
to the presence of an increased internal water interface. 
As the DSPC is hydrophobic in nature, the increasing 
amount of internal water may lead it to become relatively 
enriched in the surface lipid layer. Numerical calculations 
show that as the number of water molecules increases 
inside the LNP there is a relative decrease in the volume 
not occupied by water inside the LNPs (see SI for details 
of the calculations). That volume corresponds to the 
space were DSPC is located. This might be supported by 
the observed change in DNP enhancement values of the 
DSPC and DMPE-PEG components in samples 2 and 3 
in Figure 4. However, it is not observed for sample 4, and 
the changes are at the limit of our signal to noise ratios, 
so may not be significant. This will be investigated 
further in future work. 
 
 
Figure 4. Histogram of experimentally measured average enhancement (! : average of 8 longest polarization delays) of 
the different LNP components DSPC (pink), DMPE-PEG 2000 (purple), alkane (green) and cholesterol as well as cationic 
lipid (blue) for samples 1 (a), 3 (b), 2 (d) and 4 (c). Respective calculated enhancements values for each LNP component 
from numerical spin diffusion for Model I (gray) and Model II (black) are shown for comparison. 
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Figure 5. Scheme illustrating the increase in number average size of the LNP as a function of water content which may be dependent 
on the hydrophilicity of the cargo encapsulated, where blue illustrates bulk radical solution, gray core LNP and black surface layer.  
Finally, as regards the cargo, the 31P experimental 
enhancement values (Figure S16) of 29 and 54 for LNP 
containing 100% and 50% phosphorothioated siRNA, 
respectively. The 13C and 31P DNP enhancements are 
directly comparable because in both cases CP is used to 
transfer DNP enhanced 1H polarization to the observed 
nuclei. As can be seen in the SI, the average enhancement 
measured for the PO43- resonance (corresponding to 
DSPC and DMPE-PEG) is the same as the average for the 
13C resonances in DSPC and DMPE-PEG. Hence, the 
numerical spin diffusion simulations using Model II for 
the siRNA cargoes might provide insight on the 
localization inside the LNP domain. As described above, 
the simulations suggest that for sample 3, the cargo is 
situated inside the sub-core and for sample 2 it is located 
in the surface layer (see Figure 4). This result is in line 
with the relative hydrophilicity of siRNA and mRNA.  
Conclusions 
To our knowledge, this study represents the first 
systematic experimental examination of LNPs in the 
solid-state using relayed-DNP methods, a powerful 
characterization tool, to study the stability as well as to 
elucidate their structure at the atomic level and nano-
scale. The high sensitivity of DNP enhanced NMR 
spectroscopy permits acquisition of 13C and 31P solid-
state NMR spectra in minutes. Measurements of the DNP 
enhancement factor provides an additional parameter to 
study stability of LNPs and probe the location of the 
different components. LNPs in the presence and in the 
absence of the bioactive drugs siRNA and mRNA have 
been prepared and characterized by 31P, and 13C relayed 
DNP experiments. We observe that LNPs form 
physically stable complexes with their cargo by 
monitoring that the 13C values as well as the enhancement 
factors are constant over a 94-day period. 
Phosphorus and carbon chemical shifts are good probes 
to distinguish between the various constituents of the 
LNP and determine their morphology by estimating the 
relative position of each components. Higher DNP 
enhancements are expected for LNP components located 
at the surface due to their proximity to the biradical then 
components buried inside the domain.  The LNPs in this 
study are 50 nm in diameter size and are polarized 
instantly, hence the observed 13C and 31P enhancements 
profiles for all LNP components form a plateau over long 
polarization delays. The enhancement values as a 
function of polarization delays are interpreted using two 
types of numerical spin diffusion models: (i) 
homogeneous core and (ii) layer model to elucidate the 
structure of LNPs. The experimental data agreed best 
with the layer model which predicts an LNP structure 
enriched of both DMPE-PEG 2000 and DSPC at the 
surface and a dense core composed of the cationic lipid 
and cholesterol. This is also the first evidence of the 
structure of LNPs forming a DSPC and DMPE-PEG 2000 
lipid rich surface layer in the presence or absence of 
cargoes.  
 31P CSA values of the PO43- groups of either the LNP 
or siRNA are independent of their environment, which 
demonstrates that electrostatic interactions between 
siRNA and LNPs are weak for these types of system. The 
ε(31P) values as a function of polarization delay of the 
cargoes can be interpreted using spin diffusion model in 
order to locate its position in the LNP domain. In that 
context, we observe that for sample 3, the cargo is located 
in the sub-core of the LNP, and for sample 2 it is located 
at the surface.  
In the future, elucidating the core structure will provide 
a better understanding of the mechanism of encapsulation 
of the cargo by the LNP, assisting in the and to rational 
design of future LNPs for selective cell targeting as well 
as optimization of future drug delivery LNP systems. 
Furthermore, the DNP enhanced NMR spectroscopy 
methods demonstrated here should be applicable for 
locating bioactive drugs in other advanced drug delivery 
systems. 
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1.1.Characterisation of the LNPs 
Table S1. LNP empty and LNP/cargoe entities DSL measurements.a  
Sample Encapsulation cargo (%) Z-average 
(nm) 
Polydispersity index 
(PDI)  
Number 
average (nm) 
LNP empty - 61 0.16 36 
LNP 100 % 
phosphorothioated siRNA 
99 52 0.12 36 
LNP 50 % 
phosphorothioated siRNA 
96 65 0.13 43 
LNP with siRNA 95 53 0.06 42 
LNP mRNA  98 94 0.20 53 
aAll sizes are obtained after dialysis in PBS 7.4 and before any steps of centrifugation or D2O-
washing in order to be comparable. 
 
1.2.Explanation of how the particles do not aggregate at low temperature.  
We have strong evidence that LNPs do not undergo irreversible aggregation at 100 K. In order 
to be confident that the LNPs would endure the experimental conditions of the DNP SSNMR 
measurements, e.g. quenching down to 100 K, a repeated freeze-thaw cycle test was performed. A 
cryo-protectant, 30 vol% glycerol (UltraPure Glycerol from Invitrogen by Thermo Fisher 
Scientific), was added to a sample and the sample was then instantly frozen by immersion in liquid 
nitrogen, thawed and DLS was performed. This procedure was repeated and showed that the 
freeze-thaw cycles did not have an effect on the particle size and PDI as monitored by DLS (results 
not shown here) and there seemed to be no risk of freeze induced aggregation of the LNPs. Hence, 
the LNPs (with and without cargo) size measured by DLS is the same before and after quenching 
at 100 K. In addition, the LNPs were stable still after 48 hrs when their size distributions and PDI 
were remonitored by DLS. These finding are supported by cryo-TEM images which show no sign 
of the LNPs aggregating before and after quenching. Furthermore, our DNP results support that 
 S3 
LNPs do not aggregate. If the LNP had aggregated, the numerical spin diffusion simulations would 
have predicted their domain size to have increased which would not be in agreement with the LNP 
size measure from DLS measurements, and much lower enhancement for the LNP component 
would be predicted.  
 
1.3.Preparation of LNPs and DNP samples 
LNP formulation, D2O washing, freeze-thaw stability and xRNA cargo encapsulation. D2O-LNP 
solutions with concentrations of LNP of about 60 mg/mL tailor-made for DNP-NMR were 
prepared as follows. Individual lipid stock solutions of the ionizable cationic lipid Dlin-MC3-
DMA (synthesiezd in-house at AstraZeneca), helper lipid DSPC (Avanti Polar Lipids), Cholesterol 
(Sigma-Aldrich) and PEGylated lipid DMPE-PEG 2000 (NOF Corporation), were prepared by 
dissolution in 100% ethanol and maintained at 4-8°C. Prior to LNP preparation the lipids were 
mixed together at a molar percentage ratio of 50% cationic lipid, 10% DSPC, 37.5% cholesterol 
1.5% DMPE-PEG 2k. The LNPs were prepared by mixing appropriate volumes of lipid stock 
solutions in ethanol with an aqueous phase of 100 mM RNAse free citrate buffer of pH 3 (Teknova) 
at a 1:3 mixing ratio with a mixing rate of 12 ml/min using a NanoAssemblr (Precision 
NanoSystems INc). The setup of this microfluidic mixing instrument is described in detail 
elsewhere.1 The encapsulation of xRNA was determined by the Quant-iT RiboGreen RNA Assay 
Kit (Thermo Fisher Scientific) on an EnSpire benchtop multimode plate reader (Perkin Elmer). 
The encapsulation efficiency of all samples was 96-99%. The LNPs were then dialyzed for 24 
hours against 400x sample volume phosphate-buffered saline (GIBCO by life Technoloigies) at 
pH 7.4 at 4-8°C using Slide-A-Lyzer™ G2 dialysis cassettes with a MWCO of 10K (Thermo  
Fisher Scientific). All the samples were then washed multiple times by the usage of Amicon 
ultracentrifugation filters with a MWCO of 30k in order to exchange the PBS for 99.8 atom% 
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deuterium oxide (Armar Chemicals). The samples were allowed to equilibrate overnight in 
between the wash cycles. The total lipid content as well as the individual lipid content of the LNPs 
were analyzed by LC-MS (CAD detection) in order to confirm that the molar ratios of the lipids 
was unaffected by the washing procedure (performed only for the first couple of batches, results 
shown in SI Table S2). The siRNA was a 25 nucleotide duplex strand and obtained from 
Dharmacon. The siRNA had a 0%, 50% or 100% phosphorothioated backbone. The mRNA used 
was Erythropoietin (EPO) (858 nucleotides) ARCA capped modified with 5-methylcytidine and 
pseudouridine (TriLink Biotechnologies). The empty LNPs, i.e. no xRNA load, were prepared 
using 100 mM citrate buffer as the aqueous phase. All samples were stored at 4-8°C.  
DNP sample preparation. The LNP samples were prepared with pure D2O since partial 
deuteration of the solvent is usually beneficial for DNP and the components of the LNP are fully 
protonated (see above). We estimate the overall proton concentration of the LNP formulations to 
be similar to the 90% deuterated water-glycerol solutions that typically provide the highest DNP 
enhancements. Typically, 50 µL of 12C-glycerol-d8 was transferred to an Eppendorf vial (the actual 
volume of glycerol is accurately determined by weigh, ρ = 1.25 g/ml). 70% by volume of the LNP-
D2O dispersion is then added to the glycerol to obtain a solution of 12C-glycerol-d8/LNP-D2O 
sample (7/3 v/v). The biradical polarizing agent AMUPol ( 0.5 to 2 mg) was weighed out into a 
separate Eppendorf vial. The required volume of LNP D2O-12C-glycerol-d8 solution is then 
transferred into the AMUPol vial to provide a final AMUPol concentration of 10 mM. Finally, 20-
25 µL of 12C-glycerol-d8/LNP-D2O sample (3/7 v/v) 10 mM AMUPol were transferred in a 3.2 
mm o.d. saphirre rotor and capped with a silicon plug and zirconia cap. All LNP samples were 
stored in a 4 °C refrigerator in between experiments, and new DNP samples were prepared for 
each analysis, were the LNP-D2O dispersion is shaken manually 15 times (not vortexed).  
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Table S2. Composition of LNP components in samples 1, 2, 3 and 4.a 
 
DMPE- 
PEG 
Cholesterol DSPC 
DLin-MC3 
-DMA 
sum cargo 
MW (g/mol) 2888 387 777 643   
empty LNP, 1       
m/v (mg/ml) 4.0 15.5 9.3 38.2 67  
%w/w 6.0 23.1 13.9 57.0   
LNP (100% phosphorothioated) siRNA, 2       
mv (mg/ml) 5.15 18.10 8.42 31.01 62.69  
%w/w 8.23 28.87 13.43 49.46   
LNP (50% phosphorothioated) siRNA, 3       
mv (mg/ml) 3.8 15.4 8.4 31.9 59.5 2.93 
%w/w 6.3 25.8 14.2 53.6   
LNP mRNA, 4       
mv (mg/ml) 5.35 19.12 8.54 36.93 69.94  
%w/w 7.65 27.34 12.21 52.80   
 
 
 
 
 
1.4.DNP Acquisition Parameters 
Data were acquired at École Polytechnique Fédérale de Lausanne (EPFL) using a 263 GHz/400 
MHz Avance I or III HD Bruker DNP solid-state NMR spectrometer, respectively, equipped with 
a 3.2 mm o.d. Bruker triple resonance low temperature magic angle spinning (LTMAS) probe and 
the experiments were performed at ca. 90-100 K. The sweep coil of the main magnetic field was 
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set for the microwave irradiation occurring at the 1H positive enhancement maximum of the 
AMUPol biradical. Enhancement factor, ε, is the ratio of the signal intensity with and without 
microwaves. 
13C and 31P DNP Enhanced NMR Spectroscopy. For 13C NMR (νL(13C) = 100.6 MHz at 9.4 T), 
and 31P NMR (νL(13C) = 161.9 MHz at 9.4 T), the acquisition parameters used for a typical CPMAS 
experiment are: 1-2 s repetition delay, a 1H π/2 pulse length of 2.5 μs to afford 100 kHz 1H 
decoupling using the SPINAL-64 method, a contact time of 9 and 14 ms for 13C and 31P, 
respectively, and a spinning frequency of 8, 10 or 12.5 kHz.  
 
1.5. DNP enhanced NMR Spectra 
1H DNP enhanced NMR- Presented in Figure S1 are the MAS 1H solid echo experiments of the 
three LNP samples. The isotropic chemical shift values observed are a contribution from the cryo 
protectant in the solvent, (12C-glycerol-d8 (98% deuterated) around  6 ppm), an average 
distribution of the LNP protons (cover the proton frequency range of 2-10 ppm), as well as a 
contribution from the silicone plug in the rotor (0 ppm). To verify the stability of LNPs, the spectra 
where acquired at multiple time intervals. The enhancements are constant with time with an 
average value around 110.  
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Figure S1. Experimental 1H DNP Hahn- echo MAS spectra acquired after having been stored in 
the fridge for different days (expressed to the left) with μwaves on (black trace) and off (dashed 
trace) for compound (a) 1, (b) 2 spinning at a rate between 8 or 10 kHz.  The silicone plug is 
observed on the μwaves off spectra a 0 ppm. 
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Figure S2. Experimental 13C DNP enhanced CPMAS spectra acquired with a 400 MHz/263 GHz 
DNP system for 1 (LNP empty) after having been stored in the fridge for different time periods 
(left) with microwave irradiation on (black trace) and off (dashed trace), spinning at a rate between 
8 kHz and 12.5 kHz, at 100 K, and a recycle delay of 1 s.  The silicone plug is observed on the 
μwaves on and off spectra a 0 ppm. The components of the LNP are resolved in the 13C spectra, 
they are color coded with respect to the legend described in Figure 1 of the main text and a vertical 
lines show that the chemical shifts are constant over time.  
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Table S3. 1H enhancement values over time for all LNP systems acquired with a recycle delay of 
1 s.a 
Days/System Empty LNP LNP with siRNA 
1 79(2) 106(1) 
7 117(3) 86(1) 
32 - 176(1) 
52 117(3) 58(1) 
94 66(2) 135(1) 
aError bounds are in parentheses and are calculated from the following equation: Δ" =" $/&'() + $/&'++), where S/Non or off is the signal to noise ratio for microwaves on and off. 
 
Table S4. 13C enhancement values over time for empty LNP acquired with a recycle delay of 1 s. a 
Days/resonance 30 ppm 56-69 ppm 127 ppm 170 ppm 
1 24(1) 59(3) 28(1) 28(3) 
7 40(1) 72(3) 46(2) 130(13) 
32 44(1) 91(7) 42(2) 100(25) 
52 43(1) 77(4) 41(2) 70(12) 
94 55(2) 80(3) 59(2) 73(7) 
aSee footnote for Table S4. 
 
Table S5. 13C enhancement values over time for LNP with 50% phosphorothionated siRNA 
acquired with a recycle delay of 1 s. a 
Days/resonance 30 ppm 56-69 ppm 127 ppm 170 ppm 
1 33(1) 149(7) 38(2) 19(3) 
7 31(1) 102(5) 43(2)  
32 66(2) 24(1) 26(1) 15(3) 
52 21(1) 41(2) 34(1) 32(6) 
94 34(1) 63(3) 50(2)  
aSee footnote for Table S4. 
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Table S6. 31P enhancement values over time for all LNP systems acquired with a recycle delay of 
0.2 s.a 
Days/System Empty LNP LNP with 50 % phosphorothioated  siRNA 
 lipid lipid siRNA 
1 56(11) 11(2) 29(15) 
32 48(13) 22(2) 30(6) 
aSee footnote for Table S4. 
 
An external reference, 98% enriched 13C=O-acetate, was added to compound 2 to verify the 
enhancement of the radical solution. An external reference is necessary in order to measure a 13C 
resonance which corresponds to the radical solution because the glycerol used is depleted as well 
as deuterated (12C-glycerol-98%d8) in order to observe the carbon resonances of the LNP 
components in the 40-80 ppm region. The proton spectrum is not resolved enough to distinguish 
between the LNP components and the radical solution only. Figure S3 (b) shows the spectrum of 
2 with the addition of the external reference, and in (b) the spectrum of 2 acquired four months 
later without the addition of acetate. The spectrum was acquired later in order to verify that the 
addition of an external reference did not affect the LNP spectrum. The spectra for 2 acquired with 
and without acetate have constant chemical shifts which confirms that the addition of acetate does 
not affect the integrity of the LNP. The enhancement value for the components of the LNP were 
low and equal to 11(6) with and without acetate. Furthermore, the enhancement measured on 
acetate is equal to 98 for sample 2 containing acetate. The higher enhancement of acetate compared 
to the LNP components shows that it is in proximity to the radical and hence it is located outside 
the LNPs domain. Furthermore, the value of the acetate in the radical solution is in agreement with 
the enhancements measured in the proton NMR spectra for the radical solution. 
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Figure S3. Experimental μwaves on (black trace) and μwaves off (dashed line) 13C CPMAS DNP 
spectra acquired at 8 kHz spinning speed for (a) compound 2, and (b) 2 combined with an external 
reference, 13C=O labelled-acetate. Resonances follow previous assignment and legend from Figure 
2 of main text. 
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Figure S4. Experimental 13C DNP enhanced 1H-13C HETCOR spectra acquired for sample 2 (blue) 
and 4 (red) (MAS 10 kHz). In the indirect dimension, no chemical shift of the cargo is observed 
(no cross peak in the proton 7-8 ppm region). The two sample (2 and 4) have the same resonances 
which corresponds to cross peaks of the LNP components. 
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Figure S5. (a) Experimental 31P-31P CPMAT DNP enhanced solid-state NMR spectrum for 
compound 3 (blue) acquired at 9.4 T with a MAS rates of 4 kHz. The experimental slices of the 
CPMAT (right) are extracted and shown in (b-d, blue line) for compound 3. Their simulated 
spectra are shown represented by dashed lines (c- e, respectively).  The lipids (DMPE-PEG and 
DSPC) and siRNA show distinct/different anisotropy. 
 
 
 
 
2. Diffusion Model Results 
2.1.Build up curves 
All build-up curves where measured with a saturation recovery experiment and fit with a 
stretched exponential equation which is described below: 
   $ , = - 1 − exp	(−( 567)9)    [E.1] 
where S(τ) is the intensity of the signal at the polarization time τ, A represents the equilibrium 
non-normalized signal, and beta is the stretching parameter. TB is the build-up time of the sample 
at cold temperature with or without microwaves. The ε(13C) of the ester functional group of the 
lipids can only be measured at long polarization delays, as the μwaves off spectrum for the 
quaternary carbon is not observable at short delays. 
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Table S7. Summary of 13C relaxation measurements for empty LNPs for each component measured 
using 10 mM AMUPol and 12C-glycerol-d8/LNP (30/70 v/v) solution. a 
resonance (ppm) 170(3) 127(5) 69(5) 56(7) 30(8) 
μwaves on  
Aon (au) 1.700 (0.025) 0.994 (0.009) 0.991 (0.004) 1.003 (0.004) 0.999(0.002) 
TB (s) 0.761(0.054) 0.909 (0.027) 0.899 (0.0157) 0.921 (0.013) 0.879(0.006) 
β 0.950(0.104) 0.944 (0.041) 0.941 (0.024) 0.944 (0.019) 0.995(0.009) 
μwaves off  
Aoff (au) - 0.991 (0.863) 0.954 (0.053) 0.962 (0.047) 1.006 (0.007) 
TB (s) - 1.587 (0.439) 1.224 (0.174) 1.425 (0.212) 0.943 (0.026) 
β - 0.813 (0.222) 1.107 (0.235) 1.083 (0.227) 0.895 (0.034) " - 37(2) 55(5) 48(5) 39(1) 
a Error bounds are given in parentheses, and average enhancement value at long polarization 
time.  Errors in the isotropic chemical shifts are the width at half height of the resonance. 
 
Table S8. Summary of 13C relaxation measurements of LNP with 100% phosphorothioated  siRNA 
for each component measured using 10 mM AMUPol and 12C-glycerol-d8/LNP (30/70 v/v) 
solution.a 
resonance (ppm) 171(3) 127(5) 69(5) 56(8) 29(9) 
μwaves on  
Aon (au) 0.999 (0.049) 1.001(0.008) 1.012 (0.023) 1.001(0.018) 1.001(0.008) 
TB (s) 1.36(0.135) 1.444 (0.039) 1.62 (0.126) 1.80 (0.102) 1.52 (0.031) 
β 1.099(0.221) 1.046 (0.041) 0.875 (0.078) 1.002 (0.072) 1.00 (0.028) 
μwaves off  
Aoff (au) - 0.928 (0.418) 0.894 (0.042) 1.083 (0.423) 0.967 (0.013) 
TB (s) - 1.314 (0.223) 1.089 (0.125) 3.988 (4.393) 1.576 (0.069) 
β - 0.803 (0.159) 4.083 (1.853) 0.750 (0.40) 1.007 (0.059) " - 31(2) 52(6) 58(8) 29(1) 
a see note Table S7. 
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Table S9. Summary of 13C relaxation measurements on LNP with 50% phosphorothioated  siRNA 
for each component measured using 10 mM AMUPol and 12C-glycerol-d8/LNP (30/70 v/v) 
solution.a 
resonance (ppm) 171(3) 127(5) 69(5) 56(8) 29(9) 
μwaves on  
Aon (au) 0.999 (0.03) 0.99(0.01) 1.00 (0.01) 1.00(0.01) 1.0(0.002) 
TB (s) 1.05(0.13) 1.07 (0.039) 1.08 (0.02) 1.12 (0.04) 1.08 (0.009) 
β 1.10(0.20) 1.09 (0.05) 0.89 (0.03) 1.03 (0.05) 1.01 (0.01) 
μwaves off  
Aoff (au) - 1.00 (0.05) 1.00 (0.07) 0.89(0.01) 1.0(0.002) 
TB (s) - 1.73 (0.20) 1.85 (0.41) 0.96 (0.04) 1.08 (0.02) 
β - 1.41 (0.28) 0.85 (0.03) 1.92 (0.05) 0.97 (0.2) " - 23(2) 45(5) 54(7) 30(1) 
a see note Table S7. 
 
Table S10. Summary of 13C relaxation measurements on LNP containing mRNA for each 
component measured using 10 mM AMUPol and 12C-glycerol-d8/LNP (30/70 v/v) solution.a 
 
a see note Table S7. 
 
resonance (ppm) 127(5) 69(5) 56(8) 29(9) 
μwaves on 
Aon (au) 0.98(0.01) 0.99 (0.01) 0.99 (0.02) 0.99(0.003) 
TB (s) 2.22 (0.07) 2.14 (0.09) 2.59 (0.12) 2.24 (0.02) 
β 0.98 (0.04) 0.96 (0.04) 0.91 (0.04) 0.98(0.01) 
μwaves off 
Aoff (au) 1.08 (0.03) 0.89 (0.17) 1.45(0.15) 0.99(0.07) 
TB (s) 1.73 (0.16) 2.88 (1.44) 2.09 (0.59) 2.34 (0.05) 
β 0.96 (0.11) 1.08 (0.58) 1.28 (0.57) 1.03 (0.03) " 28(1) 58(10) 49(9) 44(4) 
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Table S11. Summary of 31P relaxation measurements of sample 1 and 2 for each component 
measured using 10 mM AMUPol and 12C-glycerol-d8/LNP (30/70 v/v) solution. a 
resonance 
(ppm) 1 (10 ppm) 2 (10 ppm) 2 (67 ppm) siRNA/D2O 
3 (10 
ppm) 
3 (67 
ppm) 
4 
μwaves on    
Aon (au) 1.000 (0.023) 
0.982 
(0.013) 
0.985 
(0.011) 
1.044 
(0.052) 0.99 (0.01) 1.00 (0.01) 
1.00(0.01) 
TB (s) 0.699 (0.039) 
1.702 
(0.076) 
1.739 
(0.069) 
1.121 
(0.004) 1.26(0.02) 1.29(0.02) 
2.20(0.03) 
β 1.098 (0.082) 
1.033 
(0.067) 
1.007 
(0.056) 
1.000 
(0.050) 1.00 (0.02) 1.01 (0.02) 
0.97(0.02) 
μwaves off    
Aoff (au) 1.023 (0.028) 
0.983 
(0.019) 
0.958 
(0.0244) - 1.00 (0.02) 0.99 (0.07) 
0.97(0.03) 
TB (s) 0.868 (0.056) 
1.503 
(0.099) 
1.874 
(0.154) - 1.23(0.06) 1.43(0.26) 
2.63(0.26) 
β 1.065 (0.076) 
1.159 
(0.130) 
1.108 
(0.133) - 1.05 (0.05) 1.21 (0.28) 
0.91(0.09) 
ε 27(2) 41(2) 29(1) - 50(5) 54(4) 44(5) 
a see note Table S7. 
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2.2.Spin Diffusion Numerical Model 
The proton-proton dipolar coupling dynamics such as spin diffusion simulations were performed 
using the MATLAB software. The classical diffusion model is used and is previously described in 
detail by Schlagnitweit et al.2, Rosssini et al.3, or Pinon et al. 4 
If we assumed that polarization dynamics follows the same behavior as thermal transfer, the 
process may be described by classical diffusion process, the 2nd Fick law: 
    :;(<,>):> = ? @ ∙ ∆C(@, D) − ; <,> E;F(<)6G(<)   [E.2] 
with the following initial and boundary conditions: 
      C @, 0 = 	0  [E.3] 
      :; <I,>:< = 0  [E.4] 
where x is the distance from the center of the LNP in μm, xo is the position at the extremity of 
the system, t is the time in seconds (0 < t < ∞), P and P0 is the spontaneous and local equilibrium 
polarization, respectively, D is the diffusion rate constant at point x, T1 is the spin-lattice relaxation 
rate at point x, and ΔP is the Laplacian polarization which is dependent on the symmetry of the 
system, and here for LNPs it is spherical. Equation [E.2] may be solved using the following 
approximations, such that the boundary condition presented in equation [E.3] and [E.4] designates 
no initial polarization within the system as well as absence of polarization at the border of the 
system, respectively.  
For the LNPs, the size distribution measured by DLS measurements is reproduced using a 
Weibull distribution (see Figure S6 (a)).  The spin diffusion behavior is simulated for all size 
distribution (Figure S6 (b)). Next the sum of the weighted enhancements as a function of 
polarization delay is the best fit and is shown on the final figures (Figure S6 (c - d)). The same 
steps are followed for the buildup curves. All experimental parameters used for the modelling are 
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detailed Table S12. Modeling the size distribution was done to convince ourselves that using the 
number average determined by DLS is enough for the following itirative steps used in the 
numerical spin diffusion simulations for Model I and II. 
 
Figure S6. Example of model I proton spin diffusion for LNP empty, alkane peak (30 ppm). (a) 
Size distribution of LNPs using a Weibull distribution (max, width: 0.055, 4). (b) Enhancement as 
a function of polarization delay for each size of the LNP distribution, and in (c) is their weighted 
enhancement. (d) Sum of the weighted enhancement as a function of the polarization delay which 
gives the best fit. 
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Table S12. 13C spin diffusion parameters determined experimentally and used to numerically 
model the enhancement as a function polarization delay for LNP samples.a 
sym radius(μm) #steps tmax/s tstep/s 
T1out  
(s) 
T1in 
(s) 
εsol 
Dout 
(μm2s-1) 
Pol depol slope 
spherical 0.1+dist(k) 100 12 101 1.24 1.41 96 1·10-3 0.1 0.5 60000 
aThe LNPs are simulated as spheres, the radius is modeled on the size distribution measured by 
DLS (see Table S1) using the Weibull distribution which depends on the parameter (max, width); 
spatial steps are used for the numerical simulation (#steps); number of points (tmax) are calculated 
for the numerical simulation in a number of steps (tsteps); the enhancement of the radical solution 
(εsol), the intrinsic T1 (spin-lattice relaxation at 100 K without radical) of the LNP components 
(T1,in) and the build-up time of the DNP matrix (T1,out). The hyperpolarization (pol) and 
depolarization (dePol) through the radical solution and core are simulated, a hysteresis slope 
(slope) is used to model the passage between the exterior toward the inside of the domain. 
 
Two 1H-1H spin diffusion models are used to simulate the structure of LNPs. Model I mimics a 
homogeneous core model where all components are distributed equally in the domain. We expect 
the behavior of the enhancement as a function of polarization delay to be the same for the various 
components of the LNP. For the numerical spin diffusion simulations of model I, only one 
parameter is optimized (Din) iteratively until the minimum value is found. The spin diffusion 
coefficient inside the LNPs is expected to be different than the value found outside the LNP 
domain. The numerical spin diffusion model II aims to mimic a lipid layer at the surface of the 
LNP such as suggests the nanostructured core model. Model II simulates a layer core shell model 
were the polarization located in the layer and in the core, are integrated separately, and the entire 
sphere is integrated to provide the value of the sub-core. Model II provides different enhancement 
values for the various components depending on their spatial location; the ε values for the 
components at the surface will be higher than the value for the components located at the core. For 
the numerical spin diffusion simulations of model II, three parameters are optimized iteratively 
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until the minimum values are found (cycles are performed), the spin diffusion coefficient inside 
(Din) and in the layer (Dlay) of the LNPs as well as the layer length (L). It should be noted that the 
spin diffusion models systematically fit the experimental build-up curves inversely, i.e. the 
simulated build-up μwaves on are fit to the observed μwaves off data and vice versa. We believe 
this is a consequence of the large errors of the μwaves off build-up curves due to low S/N and 
small TB values that are close for μwaves on and off.  
 
 
Table S13. Summary of outputted optimized values (minimum, last cycle) of numerical spin 
diffusion calculations for model I and II. 
 
Model II- Layer model Model I- Homogeneous core 
1 2 3 4 1 2 3 4 
Din 
(1·103μm2s-
1) 
0.12(7.68
8) 
0.11(4.25
87) 
0.7(27.664
8) 
0.2(27.39
16) 
0.22(14.74
52) 
0.16(20.74
86) 
0.23(39.52
97) 
0.162(20.74
86) 
Dlay(1·103μ
m2s-1) 
0.1(7.738
1) 
0.11(4.66
64) 
0.12(27.10
86) 
0.3(26.98
04) - -   
Layer (1·103 
µm) 
1.2(7.788
3) 
5.0(4.669
4) 
2.4(27.664
8) 
5.5(28.57
40) - -   
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Figure S7. (a) Experimental plots of the enhancement (13C) values as a function of polarization 
time (s) for empty LNP chemical shifts at (a) 30 ppm, (b) 57 ppm, (c) 69 ppm (d) 128 ppm. For 
each resonance, inset to the right are indicated the average enhancement value as well as the 
assigned component of the resonance. Their respective 1H-1H spin diffusion modeling are overlaid 
(grey traces) using spin diffusion model I (homogeneous domain). Simulated build-up curves for 
microwaves on (black) and off (blue) are overlaid on the experimental data for the resonances at 
(e) 30 ppm, (f) 57 ppm, (g) 69 ppm (h) 128 ppm acquired with μwaves on (blue) and off (black). 
The TB on and off values in the inset of the plot are obtained from the analytical fit using the 
stretched exponential function.  
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Figure S8. (a) Experimental (circles) plots of the enhancement (13C) values as a function of 
polarization time (recycle delay, s) for LNP containing 100% phosphorothioated siRNA chemical 
shifts at (a) 30 ppm, (c) 56 ppm (e) 69 ppm and (g) 127 ppm as well as their simulation using the 
spin diffusion model I (gray traces). For each resonance, inset to the right are indicated the average 
enhancement value as well as the assigned component of the resonance. Their simulated TB curves 
are shown for μwave (black) and off (blue) are overlaid on the experimental data for the resonances 
at (e) 30 ppm, (f) 57 ppm, (g) 69 ppm (h) 128 ppm acquired with μwave on (blue) and off (black). 
Their TB values are shown on the plots are result from an analytical fit using a stretched exponential 
function. 
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Figure S9. (a) Experimental (circles) plots of the enhancement (13C) values as a function of 
polarization time (polarization delay, s) for LNP containing 50% phosphorothioated siRNA 
chemical shifts at (a) 30 ppm, (c) 56 ppm (e) 69 ppm and (g) 127 ppm as well as their simulation 
using the spin diffusion model I (grey traces). For each resonance, inset to the right are indicated 
the average enhancement value as well as the assigned component of the resonance. Their 
simulated TB curves are shown for μwaves on (black) and off (blue) are overlaid on the 
experimental data for the resonances at (e) 30 ppm, (f) 57 ppm, (g) 69 ppm (h) 128 ppm acquired 
with μwaves on (blue) and off (black). Their analytical TB values are shown on the plots are result 
from an analytical fit using a stretched exponential function. 
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Figure S10. (a) Experimental (circles) plots of the enhancement (13C) values as a function of 
polarization time (polarization delay, s) for LNP containing mRNA chemical shifts at (a) 30 ppm, 
(c) 56 ppm (e) 69 ppm and (g) 127 ppm as well as their simulation using the spin diffusion model 
I (grey traces). For each resonance, inset to the right are indicated the average enhancement value 
as well as the assigned component of the resonance. Their simulated TB curves are shown for 
μwaves (black) and off (blue) are overlaid on the experimental data for the resonances at (e) 30 
ppm, (f) 57 ppm, (g) 69 ppm (h) 128 ppm acquired with μwaves on (blue) and off (black). Their 
analytical TB values are shown on the plots are result from an analytical fit using a stretched 
exponential function. 
 S25 
 
Figure S11. Experimental (black circles) plots of the enhancement (31P) values as a function of 
polarization delay for empty LNP (a) and in the presence of the cargo (b) 50% phosphorothioated  
siRNA, (c) 100% phosphorothioated  siRNA and (d) mRNA. The phosphate of the lipids is in plot 
(a-d) and for the cargo in (c-e), as well as their simulation using the spin diffusion model I (black 
trace). Simulated build-ups with μwaves on (black trace) and off (blue trace) are observed for 
phosphate lipids in 1 (b), 50% (e) or 100% phosphorothioated 2 and 3 as well as for the cargoes (c 
and f), respectively, are overlaid over the experimental 31P saturation recovery data for μwaves on 
(blue) and off (black). Also, the TB values reported on the plots are result from an analytical fit 
using a stretched exponential. 
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Figure S12. (a) Experimental plots of the enhancement (13C) values as a function of polarization 
delay (s) for empty LNP chemical shifts at (a) 30 ppm, (b) 57 ppm, (c) 69 ppm (d) 128 ppm. The 
specified enhancements on the plots is the average value.  Their respective 1H-1H spin diffusion 
modeling using the layer model II are overlaid (colored traces: yellow for the surface layer; red for 
the core; blue surface layer and core average).  
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Figure S13. (a) Experimental plots of the enhancement (13C) values as a function of polarization 
delay (s) for LNP encapsulated 100% phosphorothioated siRNA at (a) 30 ppm, (b) 57 ppm, (c) 69 
ppm (d) 128 ppm. The specified enhancements on the plots is the average value.  Their respective 
1H-1H spin diffusion modeling using the layer model II are overlaid (colored traces: yellow for the 
surface layer; red for the core; blue surface layer and core average).  
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Figure S14. (a) Experimental plots of the enhancement (13C) values as a function of polarization 
delay (s) for LNP encapsulated 50% phosphorothioated siRNA chemical shifts at (a) 30 ppm, (b) 
57 ppm, (c) 69 ppm (d) 128 ppm. The specified enhancements on the plots is the average value. 
Their respective 1H-1H spin diffusion modeling using the layer model II are overlaid (colored 
traces: yellow for the surface layer; red for the core; blue surface layer and core average).  
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Figure S15. (a) Experimental plots of the enhancement (31C) values as a function of polarization 
delay (s) for empty LNP, diso(31P) at (a) 10 ppm, and LNP encapsulated siRNA chemical shifts at 
(b) 10 ppm, (c) 67 ppm. The specified enhancements on the plots is the average value. Their 
respective 1H-1H spin diffusion modeling using the layer model II are overlaid (colored traces: 
yellow for the surface layer; red for the core; blue surface layer and core average). 
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Figure S16. Experimental (purple circles) plots of the enhancement (31P) values as a function of 
polarization delay for empty LNP (a) and in the presence of the cargo (b-c) 100% 
phosphorothioated siRNA, LNP encapsulated mRNA (d) and LNP with (e-f) 50% 
phosphorothioated siRNA.  
 
2.3.“Back of the envelope” calculation of the volume inside LNPs 
As the DSPC is hydrophobic in nature, it will “escape” the internal water pool and become more 
surface rich. The probability of finding hydrophobic DSPC molecules at the surface of LNPs is 
verified by calculating the internal volume of LNPs that excludes its water content and associated 
electrostatic interaction radius. Below can be found the calculations and assumptions where, r1, 
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r2, dr, are the radius for dry LNP (absence of water inside), LNP with 20 % water inside,5 radius 
surrounding the water which corresponds to the assumption of electrostatic interactions used in 
COSMO solvation models, respectively. V1, V2, Vw and Ni correspond to the volumes for dry 
LNP (absence of water inside), the volume of LNP with 20 % water inside, volume of the water 
and the number of water pools. MATLAB script to calculate the relationship between the internal 
LNP volume and number of water pools, and the plots are shown in Figure S17. The calculation 
shows a clear decrease in internal volume as a function of number of increasing water pools inside 
the LNP (Figure S15). This might justify our belief that DSPC becomes surface enriched when 
encapsulating hydrophilic cargoes as it has less volume to occupy inside the LNP.  
 
%defining constants 
r1 = 18.5*1e-9;  
r2= 27*1e-9; 
  
V1=4/3*pi*r1^3; 
V2=4/3*pi*r2^3; 
  
Vw= 0.2*(V2-V1); 
  
dr=1.2*1.5*1e-10;  
  
rmin=10*2.75*1e-10; 
rmax=(3/(4*pi)*Vw)^(1/3); 
rstep=(rmax-rmin)/100; 
  
r=rmin:rstep:rmax; 
  
Vws=((r+dr)./r).^3.*Vw; 
Ni=(3/(4*pi)*Vw)./r.^3; 
  
  
figure(1) 
plot(r, Vws,'o') 
xlabel('distribution of water pools (m)') 
ylabel('Water surface in LNPs (m^3)'); 
set(gca,'fontsize',14,'box','on'); 
axis square; 
  
  
figure(2) 
plot(Ni,Vws,'o') 
set(gca,'XDir','Reverse') 
xlabel('number of water molecules') 
ylabel('Water surface in LNPs (m^3)'); 
set(gca,'fontsize',14,'box','on'); 
axis square; 
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Figure S17. LNP volume as a function of decreasing internal water pools (a), and as a function of 
water pool size. 
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